Observational studyMedicine2016

Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy.

Sumanth Karamchand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.